In the original version of this article (1), two instances of inadvertent duplication of crystal violet staining images occurred in Fig. 1D (control shRNA conditions in MDA-MB-468 and BT-20) and in Fig. 1F (0 μmol/L gefitinib control conditions in MDA-468 and BT-20). In addition, the same set of STAT3 Western blot bands was inadvertently duplicated in Fig. 3A (BT-20 and HCC1937). These errors have been corrected in the latest online HTML and PDF versions of the article. The authors regret these errors.
References
1.
Verma
N
, Müller
AK
, Kothari
C
, Panayotopoulou
E
, Kedan
A
, Selitrennik
M
, et al Targeting of PYK2 synergizes with EGFR antagonists in basal-like TNBC and circumvents HER3-associated resistance via the NEDD4–NDRG1 axis
. Cancer Res
2017
;77
:86
–99
.©2020 American Association for Cancer Research.
2020
American Association for Cancer Research.